Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2016

Open Access 01-12-2016 | Research article

Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand

Authors: Sirirat Anutrakulchai, Pisaln Mairiang, Cholatip Pongskul, Kaewjai Thepsuthammarat, Chitranon Chan-on, Bandit Thinkhamrop

Published in: BMC Health Services Research | Issue 1/2016

Login to get access

Abstract

Background

Thailand has reformed its healthcare to ensure fairness and universality. Previous reports comparing the fairness among the 3 main healthcare schemes, including the Universal Coverage Scheme (UCS), the Civil Servant Medical Benefit Scheme (CSMBS) and the Social Health Insurance (SHI) have been published. They focused mainly on provision of medication for cancers and human immunodeficiency virus infection. Since chronic kidney disease (CKD) patients have a high rate of hospitalization and high risk of death, they also require special care and need more than access to medicine. We, therefore, performed a 1-year, nationwide, evaluation on the clinical outcomes (i.e., mortality rates and complication rates) and treatment costs for hospitalized CKD patients across the 3 main health insurance schemes.

Methods

All adult in-patient CKD medical expense forms in fiscal 2010 were analyzed. The outcomes focused on were clinical outcomes, access to special care and equipment (especially dialysis), and expenses on CKD patients. Factors influencing mortality rates were evaluated by multiple logistic regression.

Results

There were 128,338 CKD patients, accounting for 236,439 admissions. The CSMBS group was older on average, had the most severe co-morbidities, and had the highest hospital charges, while the UCS group had the highest rate of complications. The mortality rates differed among the 3 insurance schemes; the crude odds ratio (OR) for mortality was highest in the CSMBS scheme. After adjustment for biological, economic, and geographic variables, the UCS group had the highest risk of in-hospital death (OR 1.13;95% confidence interval (CI) 1.07–1.20; p < 0.001) while the SHI group had lowest mortality (OR 0.87; 95% CI 0.76–0.99; p = 0.038). The circumscribed healthcare benefits and limited access to specialists and dialysis care in the UCS may account for less favorable comparison with the CSMBS and SHI groups.

Conclusions

Significant differences are observed in mortality rates among CKD patients from among the 3 main healthcare schemes. Improvements in equity of care might minimize the differences.
Appendix
Available only for authorised users
Literature
1.
Hsu M, Huang X, Yupho S. The development of universal health insurance coverage in Thailand: Challenges of population aging and informal economy. Soc Sci Med. 2015;145:227–36.CrossRefPubMed
2.
Reungjui S, Anunnatsiri S, Limwattananon C, Thavornpitak Y, Pukdeesamai P, Mairiang P. Health insurance system and healthcare provision: nationwide hospital admission data 2010. J Med Assoc Thai. 2012;95 Suppl 7:S240–53.PubMed
3.
4.
Tantivess S, Walt G. Using cost-effectiveness analyses to inform policy: the case of antiretroviral therapy in Thailand. Cost Eff Resour Alloc. 2006;4:21.CrossRefPubMedPubMedCentral
5.
Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AK. Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study. BMJ Open. 2012;2(6):e001686.CrossRefPubMedPubMedCentral
6.
Beaulière A, Le Maux A, Trehin C, Perez F. Access to antiretroviral treatment in developing countries: Which financing strategies are possible? Rev Epidemiol Sante Publique. 2010;58:171–9.CrossRefPubMed
7.
Nattrass NJ. The (political) economics of antiretroviral treatment in developing countries. Trends Microbiol. 2008;16:574–9.CrossRefPubMed
8.
Jootar S. CML treatment in Asia-Pacific region. Hematology. 2012;17 Suppl 1:S72–4.PubMed
9.
Daratha KB, Short RA, Corbett CF, Ring ME, Alicic R, Choka R, et al. Risks of subsequent hospitalization and death in patients with kidney disease. Clin J Am Soc Nephrol. 2012;7:409–16.CrossRefPubMed
10.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRefPubMed
11.
12.
13.
Anunnatsiri S, Reungjui S, Thavornpitak Y, Pukdeesamai P, Mairiang P. Disease patterns among Thai adult population: an analysis of data from the hospitalization National Health Insurance System 2010. J Med Assoc Thai. 2012;95 Suppl 7:S74–80.PubMed
14.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.CrossRef
15.
Yamaguchi J, Kasanuki H, Ishii Y, Yagi M, Ogawa H, Fujii SY, et al. Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Cardiol. 2004;93:1526–8.CrossRefPubMed
16.
Meyer A, Bunzemeier H, Hausberg M, Walter M, Roeder N, Breithardt G, et al. Impact of different stages of chronic kidney disease on in-hospital costs in patients with coronary heart disease. Nephrol Dial Transplant. 2008;23:1955–60.CrossRefPubMed
17.
Szummer K, Lundman P, Jacobson SH, Schön S, Lindbäck J, Stenestrand U, et al. Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register. J Intern Med. 2010;268:40–9.PubMed
18.
Volkmann MA, Behr PE, Burmeister JE, Consoni PR, Kalil RA, Prates PR, et al. Hidden renal dysfunction causes increased in-hospital mortality risk after coronary artery bypass graft surgery. Rev Bras Cir Cardiovasc. 2011;26:319–25.CrossRefPubMed
19.
Tessone A, Gottlieb S, Barbash IM, Garty M, Porath A, Tenenbaum A, et al. Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency. Cardiology. 2007;108:193–9.CrossRefPubMed
20.
Parikh PB, Jeremias A, Naidu SS, Brener SJ, Lima F, Shlofmitz RA, et al. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2012;80:352–7.CrossRefPubMed
21.
Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007;13:422–30.CrossRefPubMed
22.
Yang YH, Wang L, An F, Huang JH, Ma JP, Li GP, et al. Renal dysfunction and survival in hospitalized patients with chronic heart failure: a retrospective analysis. Zhonghua Xin Xue Guan Bing Za Zhi. 2009;37:729–33.PubMed
23.
Chew DP, Astley C, Molloy D, Vaile J, De Pasquale CG, Aylward P. Morbidity, mortality and economic burden of renal impairment in cardiac intensive care. Intern Med J. 2006;36:185–92.CrossRefPubMed
24.
Howell NJ, Keogh BE, Bonser RS, Graham TR, Mascaro J, Rooney SJ, et al. Mild renal dysfunction predicts in-hospital mortality and post-discharge survival following cardiac surgery. Eur J Cardiothorac Surg. 2008;34:390–5.CrossRefPubMed
25.
Ovbiagele B. Chronic kidney disease and risk of death during hospitalization for stroke. J Neurol Sci. 2011;301:46–50.CrossRefPubMed
26.
Tangcharoensathien V, Pitayarangsarit S, Patcharanarumol W, Prakongsai P, Sumalee H, Tosanguan J, et al. Promoting universal financial protection: how the Thai universal coverage scheme was designed to ensure equity. Health Res Policy Syst. 2013;11:25.CrossRefPubMedPubMedCentral
27.
Prakongsai P, Limwattananon S, Tangcharoensathien V. The equity impact of the universal coverage policy: lessons from Thailand. Adv Health Econ Health Serv Res. 2009;21:57–81.PubMed
28.
Yiengprugsawan V, Kelly M, Seubsman SA, Sleigh AC. The first 10 years of the Universal Coverage Scheme in Thailand: review of its impact on health inequalities and lessons learnt for middle-income countries. Australas Epidemiol. 2010;17:24–6.PubMedPubMedCentral
29.
Ruangratanatrai W, Lertmaharit S, Hanvoravongchai P. Equity in health personnel financing after Universal Coverage: evidence from Thai Ministry of Public Health’s hospitals from 2008–2012. Human Res Health. 2015;13:59–66.CrossRef
30.
Tangchareonsathien V, Supachutikul A, Lertiendumrong J. The social security scheme in Thailand: what lessons can be drawn? Soc Sci Med. 1999;48:913–23.CrossRef
31.
Rucker D, Hemmelgarn BR, Lin M, Manns BJ, Klarenbach SW, Ayyalasomayajula B, et al. Quality of care and mortality are worse in chronic kidney disease patients living in remote areas. Kidney Int. 2011;79:210–7.CrossRefPubMed
32.
Bello AK, Hemmelgarn B, Lin M, Manns B, Klarenbach S, Thompson S, et al. Impact of remote location on quality care delivery and relationships to adverse health outcomes in patients with diabetes and chronic kidney disease. Nephrol Dial Transplant. 2012;27:3849–55.CrossRefPubMed
33.
Dhanakijcharoen P, Sirivongs D, Aruyapitipan S, Chuengsaman P, Lumpaopong A. The “PD First” policy in Thailand: three-years experiences (2008–2011). J Med Assoc Thai. 2011;94 Suppl 4:S153–61.PubMed
Metadata
Title
Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand
Authors
Sirirat Anutrakulchai
Pisaln Mairiang
Cholatip Pongskul
Kaewjai Thepsuthammarat
Chitranon Chan-on
Bandit Thinkhamrop
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2016
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1792-9

Other articles of this Issue 1/2016

BMC Health Services Research 1/2016 Go to the issue

Research article

Implementing research results in clinical practice- the experiences of healthcare professionals

Study protocol

MAHILA: a protocol for evaluating a nurse-delivered mHealth intervention for women with HIV and psychosocial risk factors in India

Research article

Patterns of community follow-up, subsequent health service use and survival among young and mid-life adults discharged from chronic care hospitals: a retrospective cohort study

Research article

Overall satisfaction of health care users with the quality of and access to health care services: a cross-sectional study in six Central and Eastern European countries

Research article

A marketing perspective to “delight” the “patient 2.0”: new and challenging expectations for the healthcare provider

Research article

Management of hypertension and multiple risk factors to enhance cardiovascular health - a feasibility study in Singapore polyclinics